Background: Although results from studies of first‐trimester influenza vaccination and congenital heart defects (CHDs) have been reassuring, data are limited for specific CHDs.Methods: We assessed associations between reported maternal influenza vaccination, 1 month before pregnancy (B1) through end of third pregnancy month (P3), and specific CHDs using data from a multisite, population‐based case–control study. Analysis included 2,982 case children diagnosed with a simple CHD (no other cardiac involvement with or without extracardiac defects) and 4,937 control children without a birth defect with estimated delivery dates during 2006–2011. For defects with ≥5 exposed case children, we used logistic regression to estimate propensity score‐adjusted odds ratios (aORs) and 95% confidence intervals (CIs), adjusting for estimated delivery year and season; plurality; and maternal age at delivery, race/ethnicity, low folate intake, and smoking and alcohol use during B1P3.Results: Overall, 124 (4.2%) simple CHD case mothers and 197 (4.0%) control mothers reported influenza vaccination from 1 month before through the third pregnancy month. The aOR for any simple CHD was 0.97 (95% CI: 0.76–1.23). Adjusted ORs for specific simple CHDs ranged from 0.62 for hypoplastic left heart syndrome to 2.34 for total anomalous pulmonary venous return (TAPVR). All adjusted CIs included the null except for TAPVR.Conclusions: Although we cannot fully exclude that exposure misclassification may have masked risks for some CHDs, findings add to existing evidence supporting the safety of inactivated influenza vaccination during pregnancy. The TAPVR result may be due to chance, but it may help inform future studies.
19 December 2023 in Pharmacoepidemiology and Drug Safety
FEfor the National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy exposureS
for the National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy exposureS
+6
Background: Prenatal stress and social support are associated with adverse birth outcomes, including stillbirth, in the general population. Their relationship to stillbirth among fetuses with birth defects is unclear. Using data from the National Birth Defects Prevention Study and the Birth Defects Study To Evaluate Pregnancy exposureS, we examined associations between maternal stress and social support and the risk of stillbirth among fetuses with birth defects and whether these associations differed by maternal race/ethnicity. Methods: Participants self‐reported exposure to stressors and social supports experienced 3 months before conception through the first trimester. Using log‐binomial models, we estimated relative risks (RR) and 95% confidence intervals (CI) of stillbirth associated with high stress and low social support, adjusting for maternal age and race/ethnicity. We assessed additive and multiplicative effect measure modification by maternal race/ethnicity. Results: Neither stress nor social support was associated with stillbirth among fetuses with birth defects. Although we did not observe interaction, we observed increased risk of stillbirth among non‐Hispanic Black women with low stress (RR = 2.1, 95% CI = 1.3–3.6), Hispanic women with low stress (1.4, 1.0–2.1), and non‐Hispanic Black women with high stress (2.8, 1.4–5.2) compared to non‐Hispanic White women with low stress. We observed a similar pattern of results for low social support. Conclusions: Stress and social support were not associated with stillbirth in fetuses with birth defects. We observed elevated risk of stillbirth among non‐Hispanic Black women regardless of stress and social support levels.